Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression have?
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression has 23 citations in the OpenAlex counts ScholarIQ stores.
When was Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression published?
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression has 2021 year in the ScholarIQ index.
What is the open-access status of Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression?
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression has gold oa status in the ScholarIQ index.
What is the DOI of Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression?
The DOI for Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression is on the source record.
What is the PMID of Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression?
The PMID for Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression is on the source record.
What is the OpenAlex record for Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression?
The OpenAlex for Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression is on the source record.